Daniel Kapadia, M.D.
NPI 1093179681 · Pulmonary Disease Physician · Rochester, MI
Enrolled with Medicare as Practitioner - Internal Medicine · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Daniel Kapadia, M.D. is a Pulmonary Disease Physician provider in Rochester, MI (NPI 1093179681).
Provider details
- NPI number
- 1093179681
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 4301109587 (MI)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
10 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
353 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Prolonged Hospital Inpatient Or Observation Care Evaluation and Management Service(s) Beyond the Total Time for the Primary Service (when the Primary Service Has Been Selected Using Time on the Date of the Primary Service); Each Additional 15 Minutes By ThG0316 | 66 | $30 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 59 | $119 |
| Use of a Drug to Induce Depression of Consciousness By Physician Performing a Procedure (5 Years Or Older), Initial 15 Minutes99152 | 50 | $12 |
| Diagnostic Exam of Lung Airway Using an Endoscope31622 | 30 | $132 |
| Biopsy of Lobe of Lung Using an Endoscope, 1 Lobe31628 | 29 | $119 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 6 distinct drugs on file.
| Drug | Part D claims (2024) |
|---|---|
| Albuterol Sulfatebrand: Ventolin Hfa | 39 |
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 30 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 18 |
| Fluticasone Propion/Salmeterolbrand: Fluticasone-Salmeterol | 14 |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 11 |
| Prednisone | 11 |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$405 across 7 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2016-04-08
- Last updated
- 2023-04-14
- Certified
- 2023-04-14
Frequently asked questions
- What is Daniel Kapadia's NPI number?
- Daniel Kapadia's National Provider Identifier (NPI) is 1093179681, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Daniel Kapadia's specialty?
- Daniel Kapadia is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
- Where is Daniel Kapadia located?
- Daniel Kapadia's practice location on file with NPPES is 1101 W University Dr, Rochester, MI 48307-1863.
- What is Daniel Kapadia's phone number?
- The practice phone number listed in the NPPES registry for Daniel Kapadia is (734) 377-4040.
- Does Daniel Kapadia accept Medicare?
- Daniel Kapadia is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Daniel Kapadia's NPI active?
- Yes — Daniel Kapadia's NPI (1093179681) is active in the NPPES registry as of the last update on 2023-04-14.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.